<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231023059820N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-24</date_registration>
      <primary_sponsor>Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>The effect of telenursing on self-management of chronic obstructive pulmonary disease</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of telenursing on the self-efficacy and health status of patients with chronic obstructive pulmonary disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>108</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73440</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Education/Guidance, Randomization description: The samples will be divided into two test and control groups by block randomization. Blocking and sequencing of samples will be done with random allocation software ( Version 1.0.0). In order to conceal the random allocation process (allocation concealment), the names of the groups are placed in envelopes, these envelopes are numbered from 1 to 108 in the sequence provided by the software and arranged in a box. performs random allocation, the contents of the envelopes will not be in the flow, the contents of the envelopes indicate the study groups (test or control) and after making sure that the sample enters the research and obtaining written consent, the first envelope is taken in order of number and carefully According to the content of the envelope, they are placed in one of the study group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic obstructive pulmonary disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, the educational needs of each patient will be identified. The educational needs of patients will be evaluated and determined according to various aspects of self-care in patients with COPD that are emphasized in reliable nursing sources. These aspects include twelve items, knowledge and awareness related to the anatomy and physiology of the lung, description of the disease, ways to treat the disease, how to comply with the prescribed drug regimen, nutrition, balance of daily activity and rest, exercise and physical activity, elimination of harmful habits such as Smoking, the skills of how to use the oxygen device, the skills of how to use inhalation sprays correctly, effective breathing methods, prevention of lung infection and how to do lung physiotherapy at home. In each training session based on the educational needs of the patient, part of the content of this The pamphlet will teach patients over the phone. Intervention 2: Control group:The control group will receive the same routine training during hospitalization and discharge from the hospital.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data including sex, age, history of disease will be printed in the article.

When:
The start of the access period is 6 months to one year after the results are published

To whom:
Researchers working in academic and scientific institutions and graduate students

Conditions:
Available in printed article.

Where to obtain:
by Email
nrs.rajabi.sh@gmail.com

How to obtain:
Available in printed article.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shirin Rajabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 3، Plate 8، 6 Jam Alley، Abgineh St.، Kosar Koi</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3471637356</zip>
        <telephone>+98 28 3379 4824</telephone>
        <email>nrs.rajabi.sh@gmail.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shirin Rajabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 3، Plate 8، 6 Jam Alley، Abgineh St.، Kosar Koi</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3471637356</zip>
        <telephone>+98 28 3379 4824</telephone>
        <email>nrs.rajabi.sh@gmail.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>A known case of chronic obstructive pulmonary disease.
Consent to participate in the study.
have access to mobile phones and common messengers.
Do not be completely unable to do personal affairs and take care of yourself.
Do not suffer from a known mental illness and does not take psychoactive drugs.
Do not suffer from other chronic diseases such as brain, heart, kidney, cancer, etc.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient's unwillingness to continue participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, the educational needs of each patient will be identified. The educational needs of patients will be evaluated and determined according to various aspects of self-care in patients with COPD that are emphasized in reliable nursing sources. These aspects include twelve items, knowledge and awareness related to the anatomy and physiology of the lung, description of the disease, ways to treat the disease, how to comply with the prescribed drug regimen, nutrition, balance of daily activity and rest, exercise and physical activity, elimination of harmful habits such as Smoking, the skills of how to use the oxygen device, the skills of how to use inhalation sprays correctly, effective breathing methods, prevention of lung infection and how to do lung physiotherapy at home. In each training session based on the educational needs of the patient, part of the content of this The pamphlet will teach patients over the phone.</i_keyword>
      <i_keyword>Control group:The control group will receive the same routine training during hospitalization and discharge from the hospital.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self-efficacy of patients with chronic obstructive pulmonary disease. Timepoint: The beginning of the study (before the start of the intervention), immediately after the end of the training and 1 and 3 months after the end of the intervention. Method of measurement: Self-efficacy questionnaire in patients with chronic obstructive pulmonary disease.</prim_outcome>
      <prim_outcome>Health status of patients with chronic obstructive pulmonary disease. Timepoint: The beginning of the study (before the start of the intervention), immediately after the end of the training and 1 and 3 months after the end of the intervention. Method of measurement: Koop self-assessment questionnaire of health condition.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Telenursing in patients with chronic obstructive pulmonary disease. Timepoint: In the first 3 weeks after the discharge of patients, it will be done twice a week with an interval of 3 to 4 days. Method of measurement: Use of mobile phones and common messengers.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-05</approval_date>
        <contact_name>Ethics Committee of Qazvin University of Medical Sciences</contact_name>
        <contact_address>Qazvin - Shahid Bahonar Boulevard - Qazvin University of Medical Sciences Qazvin Qazvin Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
